Aquestive Therapeutics (AQST) Current Taxes (2017 - 2020)

Aquestive Therapeutics' Current Taxes history runs 4 years deep, the most recent figure standing at $316000.0 for Q4 2020.

• On a quarterly basis, Current Taxes rose 5.33% year-over-year to $316000.0 in Q4 2020; TTM through Dec 2020 was $316000.0, a 5.33% increase from a year earlier, with the FY2020 full-year figure at $316000.0, up 5.33% from the prior year.
• Current Taxes declined to $316000.0 in Q4 2020 per AQST's latest filing, from $370000.0 in the prior quarter.
• Across five years, Current Taxes topped out at $388000.0 in Q4 2018 and bottomed at $176000.0 in Q2 2019.
• The 4-year median for Current Taxes is $327000.0 (2018), against an average of $312500.0.
• Across the five-year window, Current Taxes slumped 33.08% in 2019 and advanced 5.33% in 2020, its largest moves.
• Year by year, Current Taxes stood at $372000.0 in 2017, then gained by 4.3% to $388000.0 in 2018, then decreased by 22.68% to $300000.0 in 2019, then rose by 5.33% to $316000.0 in 2020.
• Per Business Quant, the three latest AQST Current Taxes figures stand at $316000.0 (Q4 2020), $370000.0 (Q1 2020), and $300000.0 (Q4 2019).